Hormones control essential processes like growth, metabolism, mood, and reproduction, but when their balance is disrupted, it ...

Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...

bioTheranostics, Inc's Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be ...

I am Jess Bruce Assistant Manager in Transparency Market Research (TMR). TMR is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of ...

Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial. Rate of medical ...

dvm360: What can [lecture] attendees learn about concurrent endocrine and dermatological disease?

Please provide your email address to receive an email when new articles are posted on . An assessment of free cortisol after a dexamethasone suppression test could add value to the diagnostic workup ...

I was struck by this large heading on an EPA website, “Rebuilding the Endocrine Disruptor Screening Program.” This program does not need to be rebuilt; it should be eliminated and consolidated with ...